ABCL - AbCellera Biologics Inc

Healthcare - Sector
Coverage

ABCL is currently covered by 3 analysts with average potential upside of $13.91 (84.07%) backed by 5 price targets and 13 ratings. Analyst's average stock valuation to be materialised ratio is 29.76% with an average time for price targets to be met of 15.67 days.

Most recent stock forecast was given by PUNEET SOUDA from LEERINK on 06-Jan-2023.

Highest price target for ABCL is 34, Lowest price target is 6, average price target is 20.

Best performing analysts who are covering ABCL - AbCellera Biologics Inc:

Do Kim Puneet Souda Tiago Fauth

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

18

$6.99 (63.49%)

20

1 months ago

1/4 (25%)

$10.37 (61.04%)

9

Buy

22

$10.99 (99.82%)

21

6 months 11 days ago

1/7 (14.29%)

$15 (143.34%)

14

Buy

51

$39.99 (363.22%)

52

1 years 8 months 23 days ago

1/2 (50%)

$16.37 (47.83%)

24

Show more analysts